|
⚲
|
| TYRX Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001301800 |
| Sale | 2009-07-27 ($11.0 M Offered, $11.0 M Sold) |
| Fund | |
| Phone | 7322468676 |
| Address | 1 Deer Park Drive Monmouth Junction, 08852 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Scott Requadt | |
| William Dempsey | |
| Arikha Moses | |
| Charles Cahn | |
| Arthur Pappas | |
| Ray Imp | |
| Jeff Leiden | |
| William Edelman | |
| Mike Heffernan |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Bosco Sara Yang
✚
|
0.0 | |
|
BOSE Opportunity Fund (QP), a series of BlueArc Core Alterna
✚
|
0.0 | |
|
BOSE Opportunity Fund (QP) (TE Onshore), a series of BlueArc
✚
|
0.0 | |
|
Bossa Nova Robotics Holding Corp.
✚
|
0.0 | |
|
Bosse Capital Fund LLC
✚
|
0.0 | |
|
Bosshart John
✚
|
0.0 | |
|
Boss HOG Resources LLC
✚
|
0.0 | |
|
Bostic Henry Hawes III
✚
|
0.0 | |
|
Boston Common Catholic Emerging Markets Fund LLC
✚
|
0.0 | |
|
Bosch Anthony R.
✚
|
0.0 |